Blockade of T cell costimulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis

被引:33
作者
Matsui, Y
Inobe, M
Okamoto, H
Chiba, S
Shimizu, T
Kitabatake, A
Uede, T
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Sapporo, Hokkaido 0600815, Japan
关键词
experimental autoimmune myocarditis; T cell-mediated autoimmune disease; adenovirus vector; CTLA4Ig; CD40Ig; immune response; T cell anergy; gene-transfer;
D O I
10.1006/jmcc.2001.1511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Y. MATSUI. M. INOBE, H. OKAMOTO, S. CHIBA, T. SHIMIZU, A. KITABATAKE AND T. UEDE. Blockade of T cell Costimulatory Signals using Adenovirus Vectors Prevents both the Induction and the Progression of Experimental Autoimmune Myocarditis. Journal of Molecular and Cellular Cardiology (2002) 34, 279-295. Experimental autoimmune myocarditis (EAM) has been used as a model for human myocarditis in relation to the autoimmune mechanism and proved to be a T cell-mediated autoimmune disease. Interactions of T cell surface receptors CD28 and CD40L with their ligands B7 and CD40, respectively. on APCs are critical for antigen-specific T cell activation under physiological and pathological conditions. To achieve effective inhibition of these interactions, we have constructed adenovirus vectors containing CTLA4Ig (AdexCTLA4Ig) and CD40Ig (AdexCD40Ig) and examined the effects of these adenovirus vectors in preventing EAM. AdexLacZ as a control, or AdexCTLA4Ig and/or AdexCD40Ig were injected intravenously into rats on day 0 or 14 after immunization to study the preventive effects on EAM in the T cell activation phase or inflammatory phase. Disease severity was estimated by the macroscopic and microscopic findings of the heart. heart weight to body weight ratios, and cellular and humoral immune responses on day 21. The onset of EAM after AdexCTLA4Ig or AdexCD40Ig treatment on day 0 was completely inhibited and antigen-specific lymphocyte proliferation was significantly reduced in those adenovirus-treatment groups, suggesting that those therapies induce antigen-specific T cell anergy. Moreover, significant reduction in disease severity was achieved after the adenovirus vector treatment even on day 14 compared with EAM rats. This study indicates the therapeutic potential of costimulatory pathway blockade by gene-transfer in myocarditis. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:279 / 295
页数:17
相关论文
共 43 条
[1]   Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype [J].
Afanasyeva, M ;
Wang, Y ;
Kaya, Z ;
Park, S ;
Zilliox, MJ ;
Schofield, BH ;
Hill, SL ;
Rose, NR .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :193-203
[2]   NEW PERSPECTIVES OF CD28-B7-MEDIATED T-CELL COSTIMULATION [J].
BLUESTONE, JA .
IMMUNITY, 1995, 2 (06) :555-559
[3]   T-cell costimulatory blockade in experimental chronic cardiac allograft rejection - Effects of cyclosporine and donor antigen [J].
Chandraker, A ;
Russell, ME ;
GlysingJensen, T ;
Willett, RA ;
Sayegh, MH .
TRANSPLANTATION, 1997, 63 (08) :1053-1058
[4]  
Daikh DI, 1997, J IMMUNOL, V159, P3104
[5]   Costimulatory molecules CD80 and CD86 in the rat; tissue distribution and expression by antigen-presenting cells [J].
Damoiseaux, JGMC ;
Yagita, H ;
Okumura, K ;
Vriesman, PJCV .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (06) :803-809
[6]   SUDDEN UNEXPECTED DEATH IN PERSONS LESS-THAN-40 YEARS OF AGE [J].
DRORY, Y ;
TURETZ, Y ;
HISS, Y ;
LEV, B ;
FISMAN, EZ ;
PINES, A ;
KRAMER, MR .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (13) :1388-1392
[7]   IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury [J].
Frangogiannis, NG ;
Mendoza, LH ;
Lindsey, ML ;
Ballantyne, CM ;
Michael, LH ;
Smith, CW ;
Entman, ML .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2798-2808
[8]   The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion [J].
Gramaglia, I ;
Jember, A ;
Pippig, SD ;
Weinberg, AD ;
Killeen, N ;
Croft, M .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :3043-3050
[9]   CD40 and CD154 in cell-mediated immunity [J].
Grewal, IS ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :111-135
[10]  
Hayakawa M, 1997, INT J CANCER, V71, P1091, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1091::AID-IJC28>3.0.CO